MX365880B - Vacunas para influenza de cerdos atenuadas y metodos de elaboracion y uso de las mismas. - Google Patents
Vacunas para influenza de cerdos atenuadas y metodos de elaboracion y uso de las mismas.Info
- Publication number
- MX365880B MX365880B MX2015000713A MX2015000713A MX365880B MX 365880 B MX365880 B MX 365880B MX 2015000713 A MX2015000713 A MX 2015000713A MX 2015000713 A MX2015000713 A MX 2015000713A MX 365880 B MX365880 B MX 365880B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- attenuated
- swine influenza
- making
- influenza vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Esta descripción proporciona cepas de influenza de cerdos atenuadas, particularmente aquellas producidas por la vía de un procedimiento de genética inversa, composiciones que comprenden las mismas, y métodos de producción y uso de las mismas. Las cepas atenuadas se diseñan para codificar proteínas HA que tienen sitios de glicosilación adicionales, con relación a las proteínas HA codificadas por los virus parentales virulentos correspondientes. Ventajosamente, se pueden administrar las cepas de influenza atenuadas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672398P | 2012-07-17 | 2012-07-17 | |
PCT/US2013/050000 WO2014014726A1 (en) | 2012-07-17 | 2013-07-11 | Attenuated swine influenza vaccines and methods of making and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015000713A MX2015000713A (es) | 2015-10-12 |
MX365880B true MX365880B (es) | 2019-06-18 |
Family
ID=48874529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015000713A MX365880B (es) | 2012-07-17 | 2013-07-11 | Vacunas para influenza de cerdos atenuadas y metodos de elaboracion y uso de las mismas. |
Country Status (20)
Country | Link |
---|---|
US (2) | US9216211B2 (es) |
EP (1) | EP2874656B1 (es) |
JP (1) | JP6467672B2 (es) |
KR (1) | KR102027758B1 (es) |
CN (1) | CN104582725B (es) |
AU (2) | AU2013290597B2 (es) |
BR (1) | BR112015001020B1 (es) |
CA (1) | CA2879228C (es) |
DK (1) | DK2874656T3 (es) |
EA (1) | EA033027B1 (es) |
ES (1) | ES2662022T3 (es) |
HK (1) | HK1209325A1 (es) |
HU (1) | HUE036110T2 (es) |
MX (1) | MX365880B (es) |
MY (1) | MY166879A (es) |
NZ (2) | NZ704188A (es) |
PH (1) | PH12015500095B1 (es) |
PL (1) | PL2874656T3 (es) |
PT (1) | PT2874656T (es) |
WO (1) | WO2014014726A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ704188A (en) | 2012-07-17 | 2016-04-29 | Merial Inc | Attenuated swine influenza vaccines and methods of making and use thereof |
MY191905A (en) * | 2015-12-28 | 2022-07-18 | Boehringer Ingelheim Animal Health Usa Inc | M hyo multivalent vaccine and uses thereof |
CN110225765B (zh) * | 2016-11-30 | 2024-03-12 | 勃林格殷格翰动物保健美国公司 | 减毒猪流感疫苗以及其制备和使用方法 |
CN106939355A (zh) * | 2017-03-01 | 2017-07-11 | 苏州系统医学研究所 | 一种流感病毒弱毒活疫苗毒株的筛选和鉴定方法 |
CN107064499B (zh) * | 2017-03-15 | 2019-06-18 | 青岛蔚蓝生物制品有限公司 | 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60500673A (ja) | 1983-03-08 | 1985-05-09 | コモンウエルス セラム ラボラトリ−ズ コミツシヨン | 抗原活性を有するアミノ酸配列 |
US5585250A (en) | 1993-08-20 | 1996-12-17 | The United States Of America As Represented By The Department Of Health & Human Services | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
EP1537877A3 (en) | 1996-10-11 | 2005-08-03 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
US5980912A (en) | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
AU2004274860A1 (en) | 2003-05-28 | 2005-03-31 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with a polII promoter and ribozymes |
US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
JP5666905B2 (ja) * | 2007-06-18 | 2015-02-12 | メディミューン,エルエルシー | ヘマグルチニンポリペプチド中に変化を有するインフルエンザbウイルス |
WO2009105729A2 (en) | 2008-02-21 | 2009-08-27 | Biological Mimetics, Inc. | Immunogenic influenza composition |
CN102985107A (zh) * | 2010-01-24 | 2013-03-20 | 生物模仿公司 | 免疫性流感成分 |
NZ704188A (en) * | 2012-07-17 | 2016-04-29 | Merial Inc | Attenuated swine influenza vaccines and methods of making and use thereof |
-
2013
- 2013-07-11 NZ NZ704188A patent/NZ704188A/en unknown
- 2013-07-11 ES ES13740452.1T patent/ES2662022T3/es active Active
- 2013-07-11 MY MYPI2015000100A patent/MY166879A/en unknown
- 2013-07-11 KR KR1020157004138A patent/KR102027758B1/ko active IP Right Grant
- 2013-07-11 DK DK13740452.1T patent/DK2874656T3/en active
- 2013-07-11 JP JP2015523130A patent/JP6467672B2/ja active Active
- 2013-07-11 CA CA2879228A patent/CA2879228C/en active Active
- 2013-07-11 PL PL13740452T patent/PL2874656T3/pl unknown
- 2013-07-11 EA EA201500140A patent/EA033027B1/ru not_active IP Right Cessation
- 2013-07-11 NZ NZ712713A patent/NZ712713A/en unknown
- 2013-07-11 PT PT137404521T patent/PT2874656T/pt unknown
- 2013-07-11 US US13/939,321 patent/US9216211B2/en active Active
- 2013-07-11 CN CN201380043383.4A patent/CN104582725B/zh active Active
- 2013-07-11 BR BR112015001020-2A patent/BR112015001020B1/pt active IP Right Grant
- 2013-07-11 EP EP13740452.1A patent/EP2874656B1/en active Active
- 2013-07-11 AU AU2013290597A patent/AU2013290597B2/en active Active
- 2013-07-11 WO PCT/US2013/050000 patent/WO2014014726A1/en active Application Filing
- 2013-07-11 MX MX2015000713A patent/MX365880B/es active IP Right Grant
- 2013-07-11 HU HUE13740452A patent/HUE036110T2/hu unknown
-
2015
- 2015-01-14 PH PH12015500095A patent/PH12015500095B1/en unknown
- 2015-10-14 HK HK15110019.9A patent/HK1209325A1/xx unknown
- 2015-12-21 US US14/977,485 patent/US9623105B2/en active Active
-
2016
- 2016-04-27 AU AU2016202693A patent/AU2016202693B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501839A1 (en) | St2l antagonists and methods of use | |
EP4349404A3 (en) | Respiratory virus vaccines | |
MX2016003419A (es) | Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico. | |
PH12015502553A1 (en) | Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof | |
WO2015085318A3 (en) | Targeted adaptive vaccines | |
MX2012007710A (es) | Alfa-amilasas. | |
MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
MX2013001845A (es) | Polipetidos que enlazan miostatina, composiciones y metodos. | |
MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
MX2014003308A (es) | Vacunas para el virus de la influenza y usos de las mismas. | |
MX2012009581A (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
MX2021010060A (es) | Produccion de virus en huevos aviares. | |
NZ630869A (en) | Compositions and methods for dengue virus chimeric constructs in vaccines | |
PH12015500095B1 (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
BR112015008417A2 (pt) | composição imunogênica, e, vacina | |
PH12016501968A1 (en) | Novel macrocyclic compounds | |
IN2015KN00323A (es) | ||
PH12015502082A1 (en) | Improved stability and potency of hemagglutinin | |
GB201106162D0 (en) | Combination vaccine | |
TN2013000064A1 (en) | Antibodies that bind myostatin, compositions and methods | |
WO2013168182A3 (en) | Vaccine combinations | |
GB2515669A (en) | Bacterial vaccine | |
UA109890C2 (xx) | Композиція, що включає пестицид і алкоксилат 2-пропілгептиламіну | |
WO2013102764A3 (en) | Alternative oxidase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. |
|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. |